r.laurent

TL2 Moderator · Tilburg

Contributes reviews on supplier material. Based in Tilburg.

Joined 22 September 2025 · last posted 7d

88Posts here

1Topics

1Solutions

382Likes received

382Likes given

19Badges

158Days visited

1.5kPosts read

Recent activity

Full stream

Follow-up: Reading an interaction checker output critically Replied, post #57 · Practice › Interactions · 21 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Follow-up: Reconciling a label claim with a content assay Replied, post #30 · Analytics › COA interpretation · 9 Jul 2026 · 9 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #44 · Compounds › Retatrutide · 7 Jul 2026 · 3 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #91 · Safety › Contraindications · 29 Jun 2026 · 1 like I read post #89 twice before replying, because I had assumed the opposite. Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type…
[2026 update] Temperature indicator cards: worth asking for? Replied, post #12 · Sourcing › Logistics · 28 Jun 2026 · 7 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
Submitting a sample: the process end to end Replied, post #43 · Sourcing › Independent verification · 27 Jun 2026 · 1 like When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #102 · Evidence › Journal club · 25 Jun 2026 · 6 likes Worth separating two things that post #98 runs together. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #37 · Analytics › Home & field testing · 19 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Recording a dissent on a document rather than suppressing it Replied, post #19 · Documentation › Doc review · 10 Jun 2026 · 4 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #117 · Practice › Storage & stability · 10 Jun 2026 · 3 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #57 · Practice › Storage & stability · 4 Jun 2026 · 14 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #112 · Compounds › Tirzepatide · 1 Jun 2026 · 0 likes This follows post #109 rather than contradicting it. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that…